These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9831299)

  • 1. On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues.
    Bültmann R; Tuluc F; Starke K
    Eur J Pharmacol; 1998 Oct; 359(1):95-101. PubMed ID: 9831299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues.
    Bültmann R; Tuluc F; Starke K
    Eur J Pharmacol; 1998 Jun; 351(2):209-15. PubMed ID: 9687005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta.
    Hansmann G; Bültmann R; Tuluc F; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):641-52. PubMed ID: 9402045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.
    Windscheif U; Pfaff O; Ziganshin AU; Hoyle CH; Bäumert HG; Mutschler E; Burnstock G; Lambrecht G
    Br J Pharmacol; 1995 Aug; 115(8):1509-17. PubMed ID: 8564212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
    Bültmann R; Dudeck O; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive red 2: a P2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase.
    Bültmann R; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):477-82. PubMed ID: 8751075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2.
    Tuluc F; Bültmann R; Glänzel M; Frahm AW; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):111-20. PubMed ID: 9521483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutional isomers of Reactive Blue 2 - selective P2Y-receptor antagonists?
    Glänzel M; Bültmann R; Starke K; Frahm AW
    Eur J Med Chem; 2003 Mar; 38(3):303-12. PubMed ID: 12667697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens.
    Bültmann R; Trendelenburg M; Tuluc F; Wittenburg H; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):339-44. PubMed ID: 10344533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide-evoked relaxation of rat vas deferens--a possible role for endogenous ATP released upon alpha(1)-adrenoceptor stimulation.
    Bültmann R; Starke K
    Eur J Pharmacol; 2001 Jun; 422(1-3):197-202. PubMed ID: 11430931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.
    Wittenburg H; Bültmann R; Pause B; Ganter C; Kurz G; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):491-7. PubMed ID: 8897453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A contraction-mediating receptor for UTP, presumably P2Y2, in rat vas deferens.
    Bültmann R; Klebroff W; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):196-201. PubMed ID: 10494890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.
    Bültmann R; Pause B; Wittenburg H; Kurz G; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):481-90. PubMed ID: 8897452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and pharmacology of selective P2-purinoceptor antagonists.
    Lambrecht G
    J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoconstrictor and vasodilator effects of guanine nucleotides in the rat aorta.
    Bültmann R; Hansmann G; Tuluc F; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):653-61. PubMed ID: 9402046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.
    Bültmann R; Wittenburg H; Pause B; Kurz G; Nickel P; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):498-504. PubMed ID: 8897454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
    Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
    Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature dependency of P2 receptor-mediated responses.
    Ziganshin AU; Rychkov AV; Ziganshina LE; Burnstock G
    Eur J Pharmacol; 2002 Dec; 456(1-3):107-14. PubMed ID: 12450576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide-evoked relaxation of rat vas deferens: possible mechanisms.
    Bültmann R; Klebroff W; Starke K
    Eur J Pharmacol; 2002 Feb; 436(1-2):135-43. PubMed ID: 11834257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
    Bailey SJ; Hourani SM
    Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.